Manufacturer Brand
Spravato
Spravato (Esketamine) is a breakthrough treatment for depression, especially for patients who have not found relief from traditional medications. Administered under the supervision of medical professionals, Spravato works quickly to reduce depressive symptoms and enhance mood. This nasal spray therapy offers a fast-acting, non-invasive alternative to traditional antidepressants. Find trusted clinics near you offering Spravato treatment through MDDCare and explore the potential for lasting relief.
Developed by Janssen Pharmaceuticals, Inc. / Johnson & Johnson Innovative Medicine
2,675
clinics offering Spravato
Clinics across
the United States
the United States
Manufacturer Brand
- FDA-approved for adult TRD
- Adult MDD with acute suicidal ideation or behavior
- SPRAVATO® REMS required
- At least 2 hours of monitoring
Manufacturer / Developer
Janssen Pharmaceuticals, Inc. / Johnson & Johnson Innovative Medicine
Showing 443–468 of 2,675 clinics
About this treatment
Learn more about Spravato
How it works, who it’s for, and what to expect — on the Spravato overview page.